Source: Eur Respir J 2013; 42: 1575-1585
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Trip Pia, Nossent Esther J., de Man Frances S., van den Berk Inge A.H., Boonstra Anco, Groepenhoff Herman, Leter Edward M., Westerhof Nico, Grünberg Katrien, Bogaard Harm-Jan, Vonk-Noordegraaf Anton. Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses. Eur Respir J 2013; 42: 1575-1585

Member's Comments

No comment yet.

Related content which might interest you: Histopathology of idiopathic pulmonary arterial hypertension in patients with low or normal diffusion capacity Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Eur Respir J, 55 (6) 2000041; 10.1183/13993003.00041-2020 Year: 2020 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Transferrin in patients with idiopathic pulmonary arterial hypertension: correlation with exercise capacity Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009 The change of lung diffusion capacity does not influence the prognosis in patients with pulmonary arterial hypertension associated with systemic sclerosis. Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 Cardiac function in idiopathic pulmonary arterial hypertension patients with a severely reduced diffusion capacity Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 More on idiopathic pulmonary arterial hypertension with a low diffusing capacity Source: Eur Respir J, 50 (2) 1700354; 10.1183/13993003.00354-2017 Year: 2017 Patterns of mean pulmonary artery pressure (mPAP)-flow relation changes following chronic therapy in idiopathic pulmonary arterial hypertension (IPAH) Source: Eur Respir J 2006; 28: Suppl. 50, 427s Year: 2006 ‘Idiopathic‘ pulmonary arterial hypertension with preserved lung function but co-existing parenchymal abnormalities: Response to treatment and survival Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries Year: 2012 Bosentan influence on cellular immunity parameters in patients with idiopathic arterial pulmonary hypertension Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012 Increased renin-angiotensin-aldosteron system activity in lungs of patients with idiopathic pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Comparison of exercise capacity, pulmonary functions, respiratory and peripheral muscle strength between patients with idiopathic pulmonary arterial hypertension and Eisenmenger syndrome Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012 Exercise-induced pulmonary hypertension in patients with idiopathic pulmonary fibrosis: effects of oxygen Source: Eur Respir J 2007; 30: Suppl. 51, 607s Year: 2007 Pulmonary vascular response to exercise in heart-failure patients with pulmonary hypertension: role of a pre-capillary component Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Is survival in patients with severe group 3 pulmonary hypertension influenced by targeted therapy? Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 No indication of insulin resistance in idiopathic pulmonary arterial hypertension with preserved physical activity Source: Eur Respir J, 55 (6) 1901228; 10.1183/13993003.01228-2019 Year: 2020 Increased stimulatory capacities of dendritic cells in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Noninvasive estimation of PVR using contrast enhanced MRI in patients with idiopathic pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary circulation Year: 2009